Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Hereditary cerebral hemorrhage with amyloidosis, Dutch type

Orpha number ORPHA100006
Synonym(s) HCHWA, Dutch type
HCHWA-D
Prevalence <1 / 1 000 000
Inheritance Autosomal dominant
Age of onset Adult
ICD-10
  • E85.4+
  • I68.0*
ICD-O -
OMIM
UMLS
  • C0268394
  • C2931672
MeSH
  • C537944
  • D028243
MedDRA -

Summary

Hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D) is a form of HCHWA (see this term), a group of familial central nervous system disorders, characterized by severe cerebral amyloid angiopathy (CAA), hemorrhagic and non-hemorrhagic strokes and dementia.

The prevalence is unknown. It has been seen in three Dutch families, that are most likely related (before 17th century), to date. Approximately 200-300 patients are known to be affected.

HCHWA-D presents with hemorrhagic stroke between the ages of 39-76 years (average age 50 years). In one third of cases, the initial stroke is fatal, recurrent strokes are seen in those who survive and patients often suffer from serious disability. Cognitive decline can be a presenting symptom in some cases but often occurs after the initial or recurrent strokes. Dementia is seen in the majority of patients with HCHWA-D over the age of 40. Epilepsy is also seen in half of patients who have already experienced a previous stroke.

HCHWA-D is due to a mutation in the APP gene on chromosome 21q21.2, encoding the beta-amyloid precursor protein. The mutation leads to extensive amyloid-beta deposition in the meningocortical arterioles, causing them to weaken and rupture.

The diagnosis is clear when a patient presents with a lobar hemorrhage and is known to come from an affected family. Imaging studies show diffuse white matter damage as well as hemorrhages. Genetic testing reveals a mutation in the APP gene.

Differential diagnoses include other conditions that could cause intracerebral hemorrhage such as coagulopathies, vasculitis (see these terms), CNS neoplasms, cerebral vascular malformations, ischemic stroke and antecedent trauma.

Antenatal diagnosis is possible but is rarely performed.

As HCHWA-D is inherited autosomal dominantly, genetic counseling is possible when a family member is diagnosed with the disease. Pre-symptomatic genetic testing is possible.

There is currently no acute or preventive treatment for HCHWA-D. Symptomatic treatment (with corticosteroids and antiepileptic drugs) can be given. On pragmatic grounds, antihypertensive treatment is recommended for those with mild to moderate hypertension.

The prognosis is poor. HCHWA-D is often fatal, either acutely at first presentation or, on average, 10 years after symptom onset and after multiple strokes.

Expert reviewer(s)

  • Dr Joost HAAN
  • Dr G.M. [Gisela] TERWINDT

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image

Detailed information

Summary information
Review article
  • EN (2011)Patient Inform
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.